Nadia Riverso

Biochemist II at Siemens Healthineers

Scarsdale, New York, United States

About

I’m a dedicated biochemist with experience in global assay development at Siemens Healthineers. I graduated from Emory University in 2020 with degrees in Biology and Human Health, and later earned my M.S. in Biostatistics from New York Medical College in 2025. I am passionate about healthcare, medicine, biology, and research—and driven by the impact scientific innovation can have on patients and communities. I thrive at the intersection of science and people, and I’m motivated by opportunities to collaborate, learn, and contribute to meaningful advancements in health and diagnostics.

Experience

  • Siemens Healthineers (Tarrytown, New York, United States)
    • R&D Biochemist II
      Nov 2023 - Present · 2 yrs 8 mos

    • R&D Biochemist I
      Dec 2020 - Nov 2023 · 3 yrs

  • Undergraduate Researcher at Emory University
    May 2019 - Aug 2019 · 4 mos

    This 2019 summer program is called the Research Experience for Undergraduates. Our project was funded by the National Foundation of Swimming (NFS). The research used accelerometer sensors designed by the research team, which includes myself and six other students. These sensors are placed on a swimmer’s body and measures their acceleration on x y and z planes, churning out 512 data points per second. We designed an analysis program in Matlab which converts these data points into an acceleration graph. We then analyzed these acceleration graphs in conjunction with video of the swimmers to inform the US National Team and Olympic team about how swimmers can maximize acceleration in the water and therefore maximize speed during races.

  • Undergraduate Researcher at Winship Cancer Institute of Emory University
    Aug 2018 - May 2019 · 10 mos

    Two semesters spent working at Emory University Winship Cancer Center in the Surgical Oncology Nanomedicine Research Lab, headed by Dr. Lily Yang. My project focused on inhibiting the growth of mouse breast and pancreatic cancer cells using targeted nanoparticle-carrying chemotherapeutic drugs. This experience with the development of nanoparticle technology to improve the current standard of cancer treatment gave me the opportunity to work with those in the fields of medicine and research. Some of my duties included culturing and treating cell lines, data analysis, writing reports, and adjusting treatment as the experiment progressed.